Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
8,129,343 are the two key patents that disclose the composition of semaglutide, the active ingredient in Ozempic, Wegovy, and Rybelsus
Time reminders, spending limits, cooling-off periods, and self-exclusion options are essential
Do not overthink the timing
Notable Series A funding efforts for new-to-the-scene biotechs with early phase assets include $410 million for Verdiva Bio in 2025 and $400 million for Kailera Therapeutics in late 2024
Biological effects of human exposure to environmental cadmium
US$ 24.80
US$ 28.37
US$ 24.62
US$ 29.79
US$ 25.96
US$ 26.26
